Trials / Completed
CompletedNCT04802200
Short-term Clinical Follow-up of the Vascular Closure Device MANTATM in Minimally Invasive Cardiac Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 204 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The percutaneous MANTA Vascular Closure Device is dedicated to the closure of large bore arteriotomies. It appears to be a safe and doable option for vascular access closure in patients undergoing transfemoral Transcatheter Aortic Valve Implantation. Data concerning safety and efficacy of MANTA Vascular Closure Device in Minimally Invasive Cardiac Surgery are scarce. This study aim to assess this novel collagen-based technology in minimal invasive aortic valve replacement surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collect | Data collect following a vascular closure by MANTA |
Timeline
- Start date
- 2021-03-17
- Primary completion
- 2021-10-30
- Completion
- 2021-12-31
- First posted
- 2021-03-17
- Last updated
- 2022-04-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04802200. Inclusion in this directory is not an endorsement.